Molecular and Phenotypic Characterization of ESBL- and Carbapenemase-Producing Gram-Negative Bacteria in Clinical Isolates from Peshawar, Pakistan

سال انتشار: 1404
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 13

نسخه کامل این مقاله ارائه نشده است و در دسترس نمی باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_JOMMID-13-4_006

تاریخ نمایه سازی: 19 بهمن 1404

چکیده مقاله:

Introduction: The rising prevalence of extended-spectrum β-lactamase (ESBL)-producing Gram-negative bacteria and carbapenem-resistant Enterobacteriaceae (CRE) pose significant threats to public health. Methods: This study investigated the prevalence and antibiotic resistance patterns of ESBL-producing Gram-negative bacteria isolated from various clinical samples in Peshawar, Pakistan. Out of ۴۰۰ samples, ۱۵۰ (۳۷.۵%) were ESBL-positive, including ۵۰ (۳۳.۳%) from urine, ۵۰ (۳۳.۳%) from indwelling devices, ۲۵ (۱۶.۷%) from pus, and ۲۵ (۱۶.۷%) from blood. Escherichia coli was the most prevalent species (۵۷.۳%), followed by Klebsiella pneumoniae (۳۴.۰%). Antibiotic susceptibility testing revealed that all ESBL-producing isolates (n=۱۵۰) were resistant to ampicillin, cefoperazone, and ceftazidime, excluding intermediate results as per CLSI ۲۰۲۳ guidelines. PCR assays characterized β-lactamase genes, with bla-CTX-M detected in ۹۵.۳% of ESBL-producing isolates, followed by bla-TEM (۸۰.۶%) and bla-SHV (۷۰.۶%). The Modified Hodge Test showed that ۱۴.۷% (۲۲/۱۵۰) of ESBL isolates were carbapenem-resistant, of which a concerning ۸۶.۴% (۱۹/۲۲) carried the blaNDM gene. Results: Statistical analysis revealed a significant association between sample type and ESBL positivity (χ²=۱۶.۶۷, P=۰.۰۰۰۸), with the highest prevalence in urine samples. However, no significant difference in carbapenem resistance was found between E. coli and K. pneumoniae (χ²=۰.۰, P=۱.۰۰۰). The presence of the bla_NDM gene was very strongly associated with carbapenem resistance (χ²=۱۰۱.۴۲, P<۰.۰۰۰۱; Cramer’s V=۰.۸۲). Conclusion: The high prevalence of ESBL-producing isolates, predominantly carrying the blaCTX-M gene, and the emergence of blaNDM-mediated carbapenem resistance in Peshawar highlight an urgent need for enhanced surveillance and targeted antimicrobial stewardship to guide effective treatment strategies and public health interventions.

نویسندگان

Jawad Ahmad

Institute of Biotechnology and Genetic Engineering, University of Agriculture, Peshawar, Pakistan

Hammad Ahmed Abbasi

Institute of Biotechnology and Genetic Engineering, University of Agriculture, Peshawar, Pakistan

Muhammad Atif

Center for Applied Molecular Biology, University of the Punjab, Lahore, Pakistan

Fawad Khan

Center of Biotechnology and Microbiology, University of Peshawar, Peshawar, Pakistan

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • Abrar S, Hussain S, Khan RA, Ul Ain N, Haider ...
  • Getahun H. Antimicrobial Resistance. In: Silbermann M, editor. Global Health ...
  • Temkin E, Fallach N, Almagor J, Gladstone BP, Tacconelli E, ...
  • Leung E, Weil DE, Raviglione M, Nakatani H. The WHO ...
  • Ahmad M, Hassan M, Khalid A, Tariq I, Asad MHHB, ...
  • Fritzenwanker M, Imirzalioglu C, Herold S, Wagenlehner FM, Zimmer K-P, ...
  • Matar G. ESBL-producing Escherichia coli and Klebsiella pneumoniae in two ...
  • Grau S, Fondevilla E, Echeverría-Esnal D, Alcorta A, Limon E, ...
  • Doi Y. Treatment options for carbapenem-resistant gram-negative bacterial infections. Clin ...
  • Abd El Ghany M, Fouz N, Hill-Cawthorne GA. Human movement ...
  • Lutgring JD. Carbapenem-resistant Enterobacteriaceae: an emerging bacterial threat. In: Procop ...
  • Aurilio C, Sansone P, Barbarisi M, Pota V, Giaccari LG, ...
  • Martin A, Fahrbach K, Zhao Q, Lodise T. Association between ...
  • Mondal AH, Khare K, Saxena P, Debnath P, Mukhopadhyay K, ...
  • Johansen, H. K., Moskowitz, S. M., Ciofu, O., Pressler, T., ...
  • Janda JM, Abbott SL. Bacterial identification for publication: When is ...
  • Drieux L, Brossier F, Sougakoff W, Jarlier V. Phenotypic detection ...
  • Sirot J. Detection of extended-spectrum plasmid-mediated beta-lactamases by disk diffusion. ...
  • Bezabih YM, Sabiiti W, Alamneh E, Bezabih A, Peterson GM, ...
  • Vergara A, Moreno-Morales J, Roca I, Pitart C, Kostyanev T, ...
  • BMJ Group. Risks of extended-spectrum beta-lactamases. Drug Ther Bull. ۲۰۰۸; ...
  • Castanheira M, Simner PJ, Bradford PA. Extended-spectrum β-lactamases: an update ...
  • Paterson, D. L., & Bonomo, R. A. (۲۰۰۵). Extended-spectrum β-lactamases: ...
  • Damoa-Siakwan S. Extended-spectrum beta lactamases: an overview. British Journal of ...
  • Sathyavathy K, Madhusudhan BK. Review on clinical diseases caused by ...
  • Jamil B, Bokhari MTM, Saeed A, Bokhari MZM, Hussain Z, ...
  • Bhatia R. Universal health coverage framework to combat antimicrobial resistance. ...
  • Aguilar-Bultet L, Gómez-Sanz E, García-Martín AB, Hug MA, Furger R, ...
  • Rajabnia M, Forghani MS, Hasani S, Bahadoram M, Mohammadi M, ...
  • Choudhury D, Alanbari R, Saveliev P, Sokurenko E, Fuzi M, ...
  • Garcia-Bustos V, Cabañero-Navalón MD, Lletí MS. Resistance to beta-lactams in ...
  • نمایش کامل مراجع